Back to search

France· FR:69599043

ETOPOSIDE VIATRIS 20 mg/ml, solution à diluer pour perfusion

A etoposide product containing étoposide, registered in France by VIATRIS SANTE. The same ATC class is registered in 17 of our 19 countries.

ATC L01CB01

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedETOPOSIDE VIATRIS 20 mg/ml, solution …ATCL01CB01REGISTER NO.FR:69599043PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Etoposide is registered in 17 of 19 countries.

Countries holding a registration under ATC L01CB01 (etoposide), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose

Etoposide · ATC L01CB01

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of etoposide costs, country by country.

Normalised to the WHO defined daily dose (50 mg), the median price runs from $9.95 in France to $18.65 in Switzerland — a ×1.9 gap.

  • France: $9.95 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Etoposide · price per daily dose (50 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$18.65
  • FR France$9.95
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ÉTOPOSIDE
Manufacturer
VIATRIS SANTE
Country
France (FR)
ATC code
L01CB01
ATC class
Etoposide
Defined daily dose
50 mg, O
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

  • cip13
    3400956025770
    10 flacon(s) en verre de 5 ml
  • cip13
    3400956245383
    10 flacon(s) en verre de 10 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

576 interactions on record for etoposide.

Graded by severity as the source publishes them — 30 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Etoposide · interactions on record

576 records

  • 30 severe
  • 290 moderate
  • 21 minor
  • 235 info

Most severe, free to view

  • CladribineL01BB04severe
  • AprepitantA04AD12moderate
  • RolapitantA04AD14moderate
  • EliglustatA16AX10moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Etoposide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All etoposide products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Etoposid Accord, Etoposid Ebewe
  • Belgium · Celltop, Eposin
  • Bulgaria · Eтопозид Акорд
  • Cyprus · Etoposide Accord
  • Czechia · Etoposid Ebewe, Etoposide Accord
  • Germany · Eto-Cell, Eto-Cell®
  • Denmark · Etoposid Accord, Etoposid Ebewe
  • Estonia · Etoposide Accord, Etoposide Kabi
  • Spain · Etopósido Accord, Etopósido Hikma
  • Finland · Etoposid Fresenius Kabi, Etoposide Accord
  • United Kingdom (Northern Ireland) · Etopophos, Etoposide
  • Greece · Etobion
  • Croatia · Etoposide Sandoz
  • Hungary · Etoposid Sandoz, Etoposide Accord
  • Ireland · Etoposide, Etoposide Accord Healthcare
  • Iceland · Etópósíð Accord
  • Italy · Etoposide Accord, Etoposide Hikma
  • Lithuania · Etoposid Ebewe, Etoposide Accord
  • Luxembourg · Eposin, Etoposide Accord Healthcare
  • Latvia · Etoposide Accord, Etoposide Ebewe
  • Netherlands · Eposin, Etoposide Accord
  • Norway · Etoposid Ebewe, Etoposid Fresenius Kabi
  • Poland · Etoposid Ebewe, Etopozyd Accord
  • Portugal · Etoposido Accord, Etoposido Hikma
  • Romania · Etoposid Accord, Etoposide Teva
  • Sweden · Eposin, Etopofos
  • Slovenia · Ebeposid, Eposin
  • Slovakia · Etoposid Sandoz, Etopozid Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e3b1b380-370b-4b36-a220-a4f5d2c1964c
GET /v1/drugs/e3b1b380-370b-4b36-a220-a4f5d2c1964c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "69599043",
  "date_amm": "1997-02-04",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "ÉTOPOSIDE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution à diluer pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about etoposide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.